Simon Stevens and Jim O'Neill will be topping the bill at this year's UK Bioscience Forum

Simon Stevens and Jim O’Neill will be topping the bill at this year’s UK Bioscience Forum

The UK Bioscience Forum is hotting up to be the key sector conference this Autumn, and if you don’t have a ticket booked just yet, you might want to take a look at what you’re missing…

With both NHS CEO Simon Stevens and Lord Jim O’Neill topping the bill, the conference will be addressing THE issues of the moment, and bringing together key individuals from government, the public sector, academia and industry to discuss the challenges that face the sector, and importantly the opportunities and successes that we should not ignore.

  • Brexit: we’ll be discussing the work being undertaken by BIA and others to ensure that the EU transition for the bioscience community is coherent and seamless; we’ll also be highlighting investment in the UK in the light of political developments, and addressing the issues around IP harmonisation and the changing international landscape.
  • Innovation: bioinformatics experts from the 100,000 genomes project will update us on the latest developments in the acceleration of new diagnostics and personalised care; we’ll be celebrating the work of Professor Tom Brown as BBSRC Innovator of the Year and showcasing BIA member organisations (including Cambridge Robotics and Autolus) with new innovations to share; hearing from leading microbiome specialists on how increased research in this field could affect drug discovery; and listening to case studies from the UK’s synchrotron – one of the most advanced scientific facilities in the world – on how harnessing the power of electrons at near light speed can benefit bioscience.
  • Drug development challenges: leading figures from Public Health England, GlaxoSmithKline, Review on AMR and Discuva will address conclusions from the AMR Review and what is required to move these through to successful outcomes; and we’ll be updating delegates on developments in the orphan medicine and rare disease field, demystifying the multiple routes for reimbursement and the UK and listening to a range of stakeholders
  • Best practice: our expert panel will discuss the relevance and future of the patent box, along with practical guidelines for companies of all sizes; a ‘next generation of talent’ session will present real-world data on the make-up of today’s UK private biotech boards and discuss what we can all do to support the next generation leadership of our biotech industry; and effective media relations have never been more important than in today’s multi-faceted and fast-paced media environment – our panel will provide insight into best practice on both sides of the equation.
  • Celebrate: we’ll be celebrating the fantastic work undertaken by our sector in the innovation and development of key therapies. BIA have looked at a selection of extremely challenging diseases and explored the ways that our members have worked together to provide new solutions and aids for patients in these areas.  We want to ensure that all key stakeholders understand why our sector is so important and why, as the voice of the sector, we work tirelessly to represent its interests at the highest levels.

As if all that isn’t enough, the price also includes entry to our BIA Autumn Reception to finish off a packed day with a great opportunity for networking with new contacts and catching up with old ones.

Book your ticket here – we look forward to seeing you on 20 October!

NEW UKBSF FOM 720 x 215dpi3